These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 31353966

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Simultaneous investigation of the liquid transport and swelling performance during tablet disintegration.
    Al-Sharabi M, Markl D, Mudley T, Bawuah P, Karttunen AP, Ridgway C, Gane P, Ketolainen J, Peiponen KE, Rades T, Zeitler JA.
    Int J Pharm; 2020 Jun 30; 584():119380. PubMed ID: 32407939
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. A novel zein-based dry coating tablet design for zero-order release.
    Guo HX, Shi YP.
    Int J Pharm; 2009 Mar 31; 370(1-2):81-6. PubMed ID: 19100825
    [Abstract] [Full Text] [Related]

  • 31. Development of oral dispersible tablets containing prednisolone nanoparticles for the management of pediatric asthma.
    Chen YD, Liang ZY, Cen YY, Zhang H, Han MG, Tian YQ, Zhang J, Li SJ, Yang DS.
    Drug Des Devel Ther; 2015 Mar 31; 9():5815-25. PubMed ID: 26640367
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Bioenhanced sublingual tablet of drug with limited permeability using novel surfactant binder and microencapsulated polysorbate: In vitro/in vivo evaluation.
    El-Setouhy DA, Basalious EB, Abdelmalak NS.
    Eur J Pharm Biopharm; 2015 Aug 31; 94():386-92. PubMed ID: 26086847
    [Abstract] [Full Text] [Related]

  • 34. Comparison of Disintegrant-addition Methods on the Compounding of Orodispersible Tablets.
    Mahesparan VA, Bin Abd Razak FS, Ming LC, Uddin AH, Sarker MZI, Bin LK.
    Int J Pharm Compd; 2020 Aug 31; 24(2):148-155. PubMed ID: 32196477
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Designing robust immediate release tablet formulations avoiding food effects for BCS class 3 drugs.
    Zaheer K, Langguth P.
    Eur J Pharm Biopharm; 2019 Jun 31; 139():177-185. PubMed ID: 30902732
    [Abstract] [Full Text] [Related]

  • 37. Investigation of Filler Effects on the Compounding of Freeze-dried Orodispersible Tablets Containing Annona muricata Extract.
    Azman SEN, Abd Razak FS, Kamal WHBW, Zheng GK, Ming LC, Uddin AH, Sarker ZI, Bin LK.
    Int J Pharm Compd; 2020 Jun 31; 24(6):509-514. PubMed ID: 33217741
    [Abstract] [Full Text] [Related]

  • 38. Preparation and evaluation of swelling induced-orally disintegrating tablets by microwave irradiation.
    Sano S, Iwao Y, Kimura S, Itai S.
    Int J Pharm; 2011 Sep 15; 416(1):252-9. PubMed ID: 21763765
    [Abstract] [Full Text] [Related]

  • 39. Effect of disintegrants on the properties of multiparticulate tablets comprising starch pellets and excipient granules.
    Mehta S, De Beer T, Remon JP, Vervaet C.
    Int J Pharm; 2012 Jan 17; 422(1-2):310-7. PubMed ID: 22101283
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.